Use in pregnancy:
Pregnancy category C.
Adverse events have been observed in animal reproduction studies of pregabalin. Male-mediated teratogenicity and impaired male and female fertility have been observed in animal studies.
There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in lactation: Pregabalin is present in breast milk. A decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother.
Sign Out